 | • レポートコード：QFJ1-3911 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、生物学的製剤細胞株開発の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子導入＆選択、シングルセルクローニング）、用途別市場規模（社内、アウトソーシング、ハイブリッド、ドゥ・イット・ユアセルフ（DIY））、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・生物学的製剤細胞株開発の市場動向 ・企業の競争状況、市場シェア ・生物学的製剤細胞株開発の種類別市場規模と予測2016-2027（遺伝子導入＆選択、シングルセルクローニング） ・生物学的製剤細胞株開発の用途別市場規模と予測2016-2027（社内、アウトソーシング、ハイブリッド、ドゥ・イット・ユアセルフ（DIY）） ・生物学的製剤細胞株開発の北米市場規模2016-2027（アメリカ、カナダ） ・生物学的製剤細胞株開発の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・生物学的製剤細胞株開発のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・生物学的製剤細胞株開発の中南米市場規模2016-2027（メキシコ、ブラジル） ・生物学的製剤細胞株開発の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Becton Dickinson & Company、Beckman Coulter、Boehringer Ingelheim Group、Catalent Inc.、CMC Biologics A/S、Lonza Group Ltd.、EMD Millipore、Partec (Sysmex Corporation)、ProBioGen AG、Selexis SA、Sigma-Aldrich Co. LLC.、Sony Biotechnology Inc.、Thermo Fisher Scientific Inc.） ・結論 |
Market Analysis and Insights: Global Biotherapeutics Cell Line Development Market
The global Biotherapeutics Cell Line Development market size is projected to reach US$ 75420 million by 2027, from US$ 54050 million in 2020, at a CAGR of 4.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biotherapeutics Cell Line Development market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biotherapeutics Cell Line Development market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biotherapeutics Cell Line Development market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biotherapeutics Cell Line Development market.
Global Biotherapeutics Cell Line Development Scope and Market Size
Biotherapeutics Cell Line Development market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biotherapeutics Cell Line Development market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Transfection & Selection
Single Cell Cloning
Segment by Application
In-house
Outsource
Hybrid
Do-It-Yourself (DIY)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Becton Dickinson & Company
Beckman Coulter
Boehringer Ingelheim Group
Catalent Inc.
CMC Biologics A/S
Lonza Group Ltd.
EMD Millipore
Partec (Sysmex Corporation)
ProBioGen AG
Selexis SA
Sigma-Aldrich Co. LLC.
Sony Biotechnology Inc.
Thermo Fisher Scientific Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biotherapeutics Cell Line Development Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Transfection & Selection
1.2.3 Single Cell Cloning
1.3 Market by Application
1.3.1 Global Biotherapeutics Cell Line Development Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 In-house
1.3.3 Outsource
1.3.4 Hybrid
1.3.5 Do-It-Yourself (DIY)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biotherapeutics Cell Line Development Market Perspective (2016-2027)
2.2 Biotherapeutics Cell Line Development Growth Trends by Regions
2.2.1 Biotherapeutics Cell Line Development Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biotherapeutics Cell Line Development Historic Market Share by Regions (2016-2021)
2.2.3 Biotherapeutics Cell Line Development Forecasted Market Size by Regions (2022-2027)
2.3 Biotherapeutics Cell Line Development Industry Dynamic
2.3.1 Biotherapeutics Cell Line Development Market Trends
2.3.2 Biotherapeutics Cell Line Development Market Drivers
2.3.3 Biotherapeutics Cell Line Development Market Challenges
2.3.4 Biotherapeutics Cell Line Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biotherapeutics Cell Line Development Players by Revenue
3.1.1 Global Top Biotherapeutics Cell Line Development Players by Revenue (2016-2021)
3.1.2 Global Biotherapeutics Cell Line Development Revenue Market Share by Players (2016-2021)
3.2 Global Biotherapeutics Cell Line Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biotherapeutics Cell Line Development Revenue
3.4 Global Biotherapeutics Cell Line Development Market Concentration Ratio
3.4.1 Global Biotherapeutics Cell Line Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biotherapeutics Cell Line Development Revenue in 2020
3.5 Biotherapeutics Cell Line Development Key Players Head office and Area Served
3.6 Key Players Biotherapeutics Cell Line Development Product Solution and Service
3.7 Date of Enter into Biotherapeutics Cell Line Development Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biotherapeutics Cell Line Development Breakdown Data by Type
4.1 Global Biotherapeutics Cell Line Development Historic Market Size by Type (2016-2021)
4.2 Global Biotherapeutics Cell Line Development Forecasted Market Size by Type (2022-2027)
5 Biotherapeutics Cell Line Development Breakdown Data by Application
5.1 Global Biotherapeutics Cell Line Development Historic Market Size by Application (2016-2021)
5.2 Global Biotherapeutics Cell Line Development Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biotherapeutics Cell Line Development Market Size (2016-2027)
6.2 North America Biotherapeutics Cell Line Development Market Size by Type
6.2.1 North America Biotherapeutics Cell Line Development Market Size by Type (2016-2021)
6.2.2 North America Biotherapeutics Cell Line Development Market Size by Type (2022-2027)
6.2.3 North America Biotherapeutics Cell Line Development Market Size by Type (2016-2027)
6.3 North America Biotherapeutics Cell Line Development Market Size by Application
6.3.1 North America Biotherapeutics Cell Line Development Market Size by Application (2016-2021)
6.3.2 North America Biotherapeutics Cell Line Development Market Size by Application (2022-2027)
6.3.3 North America Biotherapeutics Cell Line Development Market Size by Application (2016-2027)
6.4 North America Biotherapeutics Cell Line Development Market Size by Country
6.4.1 North America Biotherapeutics Cell Line Development Market Size by Country (2016-2021)
6.4.2 North America Biotherapeutics Cell Line Development Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biotherapeutics Cell Line Development Market Size (2016-2027)
7.2 Europe Biotherapeutics Cell Line Development Market Size by Type
7.2.1 Europe Biotherapeutics Cell Line Development Market Size by Type (2016-2021)
7.2.2 Europe Biotherapeutics Cell Line Development Market Size by Type (2022-2027)
7.2.3 Europe Biotherapeutics Cell Line Development Market Size by Type (2016-2027)
7.3 Europe Biotherapeutics Cell Line Development Market Size by Application
7.3.1 Europe Biotherapeutics Cell Line Development Market Size by Application (2016-2021)
7.3.2 Europe Biotherapeutics Cell Line Development Market Size by Application (2022-2027)
7.3.3 Europe Biotherapeutics Cell Line Development Market Size by Application (2016-2027)
7.4 Europe Biotherapeutics Cell Line Development Market Size by Country
7.4.1 Europe Biotherapeutics Cell Line Development Market Size by Country (2016-2021)
7.4.2 Europe Biotherapeutics Cell Line Development Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biotherapeutics Cell Line Development Market Size (2016-2027)
8.2 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Type
8.2.1 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Type (2016-2027)
8.3 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Application
8.3.1 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Application (2016-2027)
8.4 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region
8.4.1 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biotherapeutics Cell Line Development Market Size (2016-2027)
9.2 Latin America Biotherapeutics Cell Line Development Market Size by Type
9.2.1 Latin America Biotherapeutics Cell Line Development Market Size by Type (2016-2021)
9.2.2 Latin America Biotherapeutics Cell Line Development Market Size by Type (2022-2027)
9.2.3 Latin America Biotherapeutics Cell Line Development Market Size by Type (2016-2027)
9.3 Latin America Biotherapeutics Cell Line Development Market Size by Application
9.3.1 Latin America Biotherapeutics Cell Line Development Market Size by Application (2016-2021)
9.3.2 Latin America Biotherapeutics Cell Line Development Market Size by Application (2022-2027)
9.3.3 Latin America Biotherapeutics Cell Line Development Market Size by Application (2016-2027)
9.4 Latin America Biotherapeutics Cell Line Development Market Size by Country
9.4.1 Latin America Biotherapeutics Cell Line Development Market Size by Country (2016-2021)
9.4.2 Latin America Biotherapeutics Cell Line Development Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biotherapeutics Cell Line Development Market Size (2016-2027)
10.2 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Type
10.2.1 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Type (2016-2027)
10.3 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Application
10.3.1 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Application (2016-2027)
10.4 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country
10.4.1 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Becton Dickinson & Company
11.1.1 Becton Dickinson & Company Company Details
11.1.2 Becton Dickinson & Company Business Overview
11.1.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Introduction
11.1.4 Becton Dickinson & Company Revenue in Biotherapeutics Cell Line Development Business (2016-2021)
11.1.5 Becton Dickinson & Company Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Details
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Biotherapeutics Cell Line Development Introduction
11.2.4 Beckman Coulter Revenue in Biotherapeutics Cell Line Development Business (2016-2021)
11.2.5 Beckman Coulter Recent Development
11.3 Boehringer Ingelheim Group
11.3.1 Boehringer Ingelheim Group Company Details
11.3.2 Boehringer Ingelheim Group Business Overview
11.3.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Introduction
11.3.4 Boehringer Ingelheim Group Revenue in Biotherapeutics Cell Line Development Business (2016-2021)
11.3.5 Boehringer Ingelheim Group Recent Development
11.4 Catalent Inc.
11.4.1 Catalent Inc. Company Details
11.4.2 Catalent Inc. Business Overview
11.4.3 Catalent Inc. Biotherapeutics Cell Line Development Introduction
11.4.4 Catalent Inc. Revenue in Biotherapeutics Cell Line Development Business (2016-2021)
11.4.5 Catalent Inc. Recent Development
11.5 CMC Biologics A/S
11.5.1 CMC Biologics A/S Company Details
11.5.2 CMC Biologics A/S Business Overview
11.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Introduction
11.5.4 CMC Biologics A/S Revenue in Biotherapeutics Cell Line Development Business (2016-2021)
11.5.5 CMC Biologics A/S Recent Development
11.6 Lonza Group Ltd.
11.6.1 Lonza Group Ltd. Company Details
11.6.2 Lonza Group Ltd. Business Overview
11.6.3 Lonza Group Ltd. Biotherapeutics Cell Line Development Introduction
11.6.4 Lonza Group Ltd. Revenue in Biotherapeutics Cell Line Development Business (2016-2021)
11.6.5 Lonza Group Ltd. Recent Development
11.7 EMD Millipore
11.7.1 EMD Millipore Company Details
11.7.2 EMD Millipore Business Overview
11.7.3 EMD Millipore Biotherapeutics Cell Line Development Introduction
11.7.4 EMD Millipore Revenue in Biotherapeutics Cell Line Development Business (2016-2021)
11.7.5 EMD Millipore Recent Development
11.8 Partec (Sysmex Corporation)
11.8.1 Partec (Sysmex Corporation) Company Details
11.8.2 Partec (Sysmex Corporation) Business Overview
11.8.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Introduction
11.8.4 Partec (Sysmex Corporation) Revenue in Biotherapeutics Cell Line Development Business (2016-2021)
11.8.5 Partec (Sysmex Corporation) Recent Development
11.9 ProBioGen AG
11.9.1 ProBioGen AG Company Details
11.9.2 ProBioGen AG Business Overview
11.9.3 ProBioGen AG Biotherapeutics Cell Line Development Introduction
11.9.4 ProBioGen AG Revenue in Biotherapeutics Cell Line Development Business (2016-2021)
11.9.5 ProBioGen AG Recent Development
11.10 Selexis SA
11.10.1 Selexis SA Company Details
11.10.2 Selexis SA Business Overview
11.10.3 Selexis SA Biotherapeutics Cell Line Development Introduction
11.10.4 Selexis SA Revenue in Biotherapeutics Cell Line Development Business (2016-2021)
11.10.5 Selexis SA Recent Development
11.11 Sigma-Aldrich Co. LLC.
11.11.1 Sigma-Aldrich Co. LLC. Company Details
11.11.2 Sigma-Aldrich Co. LLC. Business Overview
11.11.3 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Introduction
11.11.4 Sigma-Aldrich Co. LLC. Revenue in Biotherapeutics Cell Line Development Business (2016-2021)
11.11.5 Sigma-Aldrich Co. LLC. Recent Development
11.12 Sony Biotechnology Inc.
11.12.1 Sony Biotechnology Inc. Company Details
11.12.2 Sony Biotechnology Inc. Business Overview
11.12.3 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Introduction
11.12.4 Sony Biotechnology Inc. Revenue in Biotherapeutics Cell Line Development Business (2016-2021)
11.12.5 Sony Biotechnology Inc. Recent Development
11.13 Thermo Fisher Scientific Inc.
11.13.1 Thermo Fisher Scientific Inc. Company Details
11.13.2 Thermo Fisher Scientific Inc. Business Overview
11.13.3 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Introduction
11.13.4 Thermo Fisher Scientific Inc. Revenue in Biotherapeutics Cell Line Development Business (2016-2021)
11.13.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Biotherapeutics Cell Line Development Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Transfection & Selection
Table 3. Key Players of Single Cell Cloning
Table 4. Global Biotherapeutics Cell Line Development Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Biotherapeutics Cell Line Development Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Biotherapeutics Cell Line Development Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Biotherapeutics Cell Line Development Market Share by Regions (2016-2021)
Table 8. Global Biotherapeutics Cell Line Development Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Biotherapeutics Cell Line Development Market Share by Regions (2022-2027)
Table 10. Biotherapeutics Cell Line Development Market Trends
Table 11. Biotherapeutics Cell Line Development Market Drivers
Table 12. Biotherapeutics Cell Line Development Market Challenges
Table 13. Biotherapeutics Cell Line Development Market Restraints
Table 14. Global Biotherapeutics Cell Line Development Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Biotherapeutics Cell Line Development Market Share by Players (2016-2021)
Table 16. Global Top Biotherapeutics Cell Line Development Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biotherapeutics Cell Line Development as of 2020)
Table 17. Ranking of Global Top Biotherapeutics Cell Line Development Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Biotherapeutics Cell Line Development Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biotherapeutics Cell Line Development Product Solution and Service
Table 21. Date of Enter into Biotherapeutics Cell Line Development Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biotherapeutics Cell Line Development Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Biotherapeutics Cell Line Development Revenue Market Share by Type (2016-2021)
Table 25. Global Biotherapeutics Cell Line Development Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Biotherapeutics Cell Line Development Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Biotherapeutics Cell Line Development Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Biotherapeutics Cell Line Development Revenue Market Share by Application (2016-2021)
Table 29. Global Biotherapeutics Cell Line Development Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Biotherapeutics Cell Line Development Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Biotherapeutics Cell Line Development Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Biotherapeutics Cell Line Development Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Biotherapeutics Cell Line Development Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Biotherapeutics Cell Line Development Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Biotherapeutics Cell Line Development Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Biotherapeutics Cell Line Development Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Biotherapeutics Cell Line Development Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Biotherapeutics Cell Line Development Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Biotherapeutics Cell Line Development Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Biotherapeutics Cell Line Development Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Biotherapeutics Cell Line Development Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Biotherapeutics Cell Line Development Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Biotherapeutics Cell Line Development Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Biotherapeutics Cell Line Development Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Biotherapeutics Cell Line Development Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Biotherapeutics Cell Line Development Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Biotherapeutics Cell Line Development Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Biotherapeutics Cell Line Development Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Biotherapeutics Cell Line Development Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Biotherapeutics Cell Line Development Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Biotherapeutics Cell Line Development Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Biotherapeutics Cell Line Development Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Biotherapeutics Cell Line Development Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Biotherapeutics Cell Line Development Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Biotherapeutics Cell Line Development Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Biotherapeutics Cell Line Development Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country (2022-2027) & (US$ Million)
Table 61. Becton Dickinson & Company Company Details
Table 62. Becton Dickinson & Company Business Overview
Table 63. Becton Dickinson & Company Biotherapeutics Cell Line Development Product
Table 64. Becton Dickinson & Company Revenue in Biotherapeutics Cell Line Development Business (2016-2021) & (US$ Million)
Table 65. Becton Dickinson & Company Recent Development
Table 66. Beckman Coulter Company Details
Table 67. Beckman Coulter Business Overview
Table 68. Beckman Coulter Biotherapeutics Cell Line Development Product
Table 69. Beckman Coulter Revenue in Biotherapeutics Cell Line Development Business (2016-2021) & (US$ Million)
Table 70. Beckman Coulter Recent Development
Table 71. Boehringer Ingelheim Group Company Details
Table 72. Boehringer Ingelheim Group Business Overview
Table 73. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product
Table 74. Boehringer Ingelheim Group Revenue in Biotherapeutics Cell Line Development Business (2016-2021) & (US$ Million)
Table 75. Boehringer Ingelheim Group Recent Development
Table 76. Catalent Inc. Company Details
Table 77. Catalent Inc. Business Overview
Table 78. Catalent Inc. Biotherapeutics Cell Line Development Product
Table 79. Catalent Inc. Revenue in Biotherapeutics Cell Line Development Business (2016-2021) & (US$ Million)
Table 80. Catalent Inc. Recent Development
Table 81. CMC Biologics A/S Company Details
Table 82. CMC Biologics A/S Business Overview
Table 83. CMC Biologics A/S Biotherapeutics Cell Line Development Product
Table 84. CMC Biologics A/S Revenue in Biotherapeutics Cell Line Development Business (2016-2021) & (US$ Million)
Table 85. CMC Biologics A/S Recent Development
Table 86. Lonza Group Ltd. Company Details
Table 87. Lonza Group Ltd. Business Overview
Table 88. Lonza Group Ltd. Biotherapeutics Cell Line Development Product
Table 89. Lonza Group Ltd. Revenue in Biotherapeutics Cell Line Development Business (2016-2021) & (US$ Million)
Table 90. Lonza Group Ltd. Recent Development
Table 91. EMD Millipore Company Details
Table 92. EMD Millipore Business Overview
Table 93. EMD Millipore Biotherapeutics Cell Line Development Product
Table 94. EMD Millipore Revenue in Biotherapeutics Cell Line Development Business (2016-2021) & (US$ Million)
Table 95. EMD Millipore Recent Development
Table 96. Partec (Sysmex Corporation) Company Details
Table 97. Partec (Sysmex Corporation) Business Overview
Table 98. Partec (Sysmex Corporation) Revenue in Biotherapeutics Cell Line Development Business (2016-2021) & (US$ Million)
Table 99. Partec (Sysmex Corporation) Recent Development
Table 100. ProBioGen AG Company Details
Table 101. ProBioGen AG Business Overview
Table 102. ProBioGen AG Biotherapeutics Cell Line Development Product
Table 103. ProBioGen AG Revenue in Biotherapeutics Cell Line Development Business (2016-2021) & (US$ Million)
Table 104. ProBioGen AG Recent Development
Table 105. Selexis SA Company Details
Table 106. Selexis SA Business Overview
Table 107. Selexis SA Biotherapeutics Cell Line Development Product
Table 108. Selexis SA Revenue in Biotherapeutics Cell Line Development Business (2016-2021) & (US$ Million)
Table 109. Selexis SA Recent Development
Table 110. Sigma-Aldrich Co. LLC. Company Details
Table 111. Sigma-Aldrich Co. LLC. Business Overview
Table 112. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Product
Table 113. Sigma-Aldrich Co. LLC. Revenue in Biotherapeutics Cell Line Development Business (2016-2021) & (US$ Million)
Table 114. Sigma-Aldrich Co. LLC. Recent Development
Table 115. Sony Biotechnology Inc. Company Details
Table 116. Sony Biotechnology Inc. Business Overview
Table 117. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Product
Table 118. Sony Biotechnology Inc. Revenue in Biotherapeutics Cell Line Development Business (2016-2021) & (US$ Million)
Table 119. Sony Biotechnology Inc. Recent Development
Table 120. Thermo Fisher Scientific Inc. Company Details
Table 121. Thermo Fisher Scientific Inc. Business Overview
Table 122. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Product
Table 123. Thermo Fisher Scientific Inc. Revenue in Biotherapeutics Cell Line Development Business (2016-2021) & (US$ Million)
Table 124. Thermo Fisher Scientific Inc. Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biotherapeutics Cell Line Development Market Share by Type: 2020 VS 2027
Figure 2. Transfection & Selection Features
Figure 3. Single Cell Cloning Features
Figure 4. Global Biotherapeutics Cell Line Development Market Share by Application: 2020 VS 2027
Figure 5. In-house Case Studies
Figure 6. Outsource Case Studies
Figure 7. Hybrid Case Studies
Figure 8. Do-It-Yourself (DIY) Case Studies
Figure 9. Biotherapeutics Cell Line Development Report Years Considered
Figure 10. Global Biotherapeutics Cell Line Development Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Biotherapeutics Cell Line Development Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Biotherapeutics Cell Line Development Market Share by Regions: 2020 VS 2027
Figure 13. Global Biotherapeutics Cell Line Development Market Share by Regions (2022-2027)
Figure 14. Global Biotherapeutics Cell Line Development Market Share by Players in 2020
Figure 15. Global Top Biotherapeutics Cell Line Development Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biotherapeutics Cell Line Development as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Biotherapeutics Cell Line Development Revenue in 2020
Figure 17. Global Biotherapeutics Cell Line Development Revenue Market Share by Type (2016-2021)
Figure 18. Global Biotherapeutics Cell Line Development Revenue Market Share by Type (2022-2027)
Figure 19. North America Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Biotherapeutics Cell Line Development Market Share by Type (2016-2027)
Figure 21. North America Biotherapeutics Cell Line Development Market Share by Application (2016-2027)
Figure 22. North America Biotherapeutics Cell Line Development Market Share by Country (2016-2027)
Figure 23. United States Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Biotherapeutics Cell Line Development Market Share by Type (2016-2027)
Figure 27. Europe Biotherapeutics Cell Line Development Market Share by Application (2016-2027)
Figure 28. Europe Biotherapeutics Cell Line Development Market Share by Country (2016-2027)
Figure 29. Germany Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Biotherapeutics Cell Line Development Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Biotherapeutics Cell Line Development Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Biotherapeutics Cell Line Development Market Share by Region (2016-2027)
Figure 39. China Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Biotherapeutics Cell Line Development Market Share by Type (2016-2027)
Figure 47. Latin America Biotherapeutics Cell Line Development Market Share by Application (2016-2027)
Figure 48. Latin America Biotherapeutics Cell Line Development Market Share by Country (2016-2027)
Figure 49. Mexico Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Biotherapeutics Cell Line Development Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Biotherapeutics Cell Line Development Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Biotherapeutics Cell Line Development Market Share by Country (2016-2027)
Figure 55. Turkey Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Biotherapeutics Cell Line Development Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Becton Dickinson & Company Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2016-2021)
Figure 59. Beckman Coulter Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2016-2021)
Figure 60. Boehringer Ingelheim Group Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2016-2021)
Figure 61. Catalent Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2016-2021)
Figure 62. CMC Biologics A/S Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2016-2021)
Figure 63. Lonza Group Ltd. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2016-2021)
Figure 64. EMD Millipore Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2016-2021)
Figure 65. Partec (Sysmex Corporation) Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2016-2021)
Figure 66. ProBioGen AG Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2016-2021)
Figure 67. Selexis SA Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2016-2021)
Figure 68. Sigma-Aldrich Co. LLC. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2016-2021)
Figure 69. Sony Biotechnology Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2016-2021)
Figure 70. Thermo Fisher Scientific Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の不死化細胞株市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Immortalized Cell Line Market The global Immortalized Cell Line market size is projected to reach US$ 3636.7 million by 2027, from US$ 2461.3 million in 2020, at a CAGR of 5.3% during 2021-2027. With industry-standard accuracy in analysis and high data integrity,…- 世界のグリア細胞株由来神経栄養因子市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Glial Cell Line Derived Neurotrophic Factor Market The global Glial Cell Line Derived Neurotrophic Factor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
- 世界の樹状細胞癌ワクチン免疫療法市場規模・現状・予測（2021年-2027年） Dendritic cells (DCs) are one of the major antigen-presenting cells found in lymphoid organs. Main function of the dendritic cells is antigen display and activation of T-cells. Antigen display presents the identity of pathogen to T-cells for their identification and elimination from the body. These …
- 世界の免疫細胞療法市場規模・現状・予測（2021年-2027年） Immuno-Cell Therapy is known as a systemic treatment with minimal adverse reaction in cancer treatment. Basic concept of the therapy is to strengthen immune function of human body for elimination of any abnormal cells such as virus-infected or malignant cells from the body. Market Analysis and Insig…
- 世界の単一細胞シーケンシング市場規模・現状・予測（2021年-2027年） Cells are the basic unit of biology. Single-cell sequencing refers to the relatively simple genome of single-cell microorganisms in DNA research, and the larger and more complex human cell genome. Common applications are in cancer research. Market Analysis and Insights: Global Single Cell Sequencing…